BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 31118110)

  • 1. Complement 3
    Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
    Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow Cytometric Detection of PrP
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
    Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
    Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
    Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
    J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
    Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
    Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation, Microglia, and Cell-Association during Prion Disease.
    Carroll JA; Chesebro B
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30650564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An astrocyte cell line that differentially propagates murine prions.
    Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
    J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia in prion diseases.
    Aguzzi A; Zhu C
    J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-1 in prion disease-associated astrocyte activation.
    Schultz J; Schwarz A; Neidhold S; Burwinkel M; Riemer C; Simon D; Kopf M; Otto M; Baier M
    Am J Pathol; 2004 Aug; 165(2):671-8. PubMed ID: 15277240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.
    Makarava N; Chang JC; Molesworth K; Baskakov IV
    Neurobiol Dis; 2020 Apr; 137():104783. PubMed ID: 32001329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes accumulate 4-hydroxynonenal adducts in murine scrapie and human Creutzfeldt-Jakob disease.
    Andreoletti O; Levavasseur E; Uro-Coste E; Tabouret G; Sarradin P; Delisle MB; Berthon P; Salvayre R; Schelcher F; Negre-Salvayre A
    Neurobiol Dis; 2002 Dec; 11(3):386-93. PubMed ID: 12586548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory response of microglia to prions is controlled by sialylation of PrP
    Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
    Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-cell autonomous astrocyte-mediated neuronal toxicity in prion diseases.
    Kushwaha R; Sinha A; Makarava N; Molesworth K; Baskakov IV
    Acta Neuropathol Commun; 2021 Feb; 9(1):22. PubMed ID: 33546775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Homeostatic Microglia Signature in Prion Diseases.
    Wang Y; Hartmann K; Thies E; Mohammadi B; Altmeppen H; Sepulveda-Falla D; Glatzel M; Krasemann S
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Situ Temporospatial Characterization of the Glial Response to Prion Infection.
    Michael AV; Greenlee JJ; Harm TA; Moore SJ; Zhang M; Lind MS; Greenlee MHW; Smith JD
    Vet Pathol; 2020 Jan; 57(1):90-107. PubMed ID: 31331254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner.
    Kranich J; Krautler NJ; Falsig J; Ballmer B; Li S; Hutter G; Schwarz P; Moos R; Julius C; Miele G; Aguzzi A
    J Exp Med; 2010 Sep; 207(10):2271-81. PubMed ID: 20837697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte-to-neuron intercellular prion transfer is mediated by cell-cell contact.
    Victoria GS; Arkhipenko A; Zhu S; Syan S; Zurzolo C
    Sci Rep; 2016 Feb; 6():20762. PubMed ID: 26857744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurons and astrocytes respond to prion infection by inducing microglia recruitment.
    Marella M; Chabry J
    J Neurosci; 2004 Jan; 24(3):620-7. PubMed ID: 14736847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia Are Critical in Host Defense against Prion Disease.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29769333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.